BUY The Jammu & Kashmir Bank Limited — Kunal Saraogi
byKunal SaraogiHorizon: 1 year16 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Long-term trend bullish — 200-day average rising over the past quarter
Technicals · trend·6 Nov · yesterday
Jammu & Kashmir Bank reported Q2 FY2026-27 net profit of Rs 546.36 crore, up 28.8% sequentially and 10.6% year-on-year, alongside improved asset quality and business growth.
BSE · Company Update·22 Oct · 2w ago
J&K Bank reported a 28.8% QoQ and 10.6% YoY increase in net profit to Rs 546.36 crore for Q2 FY2026-27, alongside improved asset quality and 19.38% YoY growth in total business.
NSE · Press Release·22 Oct · 2w ago
REVIEWED FINANCIAL RESULTS (STANDALONE & CONSOLIDATED) OF THE BANK FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER, 2026
BSE · Board Meeting·22 Oct · 2w ago
Jammu & Kashmir Bank has completed the sale of a 0.5% stake in PNB Metlife India Insurance Company Limited for approximately INR 120.1 crore.
BSE · Company Update·16 Oct · 3w ago
The bank has completed the sale of a 0.5% stake in PNB Metlife India Insurance Company Limited to MetLife International Holdings, LLC for approximately 120 crore rupees.
NSE · Agreements·16 Oct · 3w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on The Jammu & Kashmir Bank
- BUY — Kunal Saraogi5 Nov 2026 · ~1 year · target ₹170 · Active
- BUY — Anand James, Geojit Investments21 Oct 2026 · ~3 months · target ₹154 · SL hit
- BUY — Sumeet Bagadia, Choice Broking19 Oct 2026 · ~2 weeks · target ₹146 · SL hit
- BUY — Mehul Kothari, Anand Rathi19 Oct 2026 · ~2 weeks · target ₹160 · SL hit
- BUY — Sumeet Bagadia, Choice Broking13 Oct 2026 · ~2 weeks · target ₹146 · SL hit
More from Kunal Saraogi
- BUY Shilpa Medicare6 Nov 2026 · ~1 year · target ₹1,160 · Active
- BUY AstraZeneca Pharma India6 Nov 2026 · ~1 year · target ₹8,800 · Active
- BUY BSE6 Nov 2026 · ~1 year · target ₹3,950 · Active
- BUY KPIT Technologies6 Nov 2026 · ~2 weeks · target ₹600 · Active
- BUY The Jammu & Kashmir Bank5 Nov 2026 · ~1 year · target ₹170 · Active

